These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 18808358

  • 1. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.
    Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ.
    Clin Infect Dis; 2008 Nov 01; 47(9):1162-70. PubMed ID: 18808358
    [Abstract] [Full Text] [Related]

  • 2. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina.
    Goorhuis A, Legaria MC, van den Berg RJ, Harmanus C, Klaassen CH, Brazier JS, Lumelsky G, Kuijper EJ.
    Clin Microbiol Infect; 2009 Dec 01; 15(12):1080-6. PubMed ID: 19438624
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.
    Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ.
    Clin Microbiol Infect; 2009 Dec 01; 15(12):1087-92. PubMed ID: 19624512
    [Abstract] [Full Text] [Related]

  • 8. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
    Debast SB, Vaessen N, Choudry A, Wiegers-Ligtvoet EA, van den Berg RJ, Kuijper EJ.
    Clin Microbiol Infect; 2009 May 01; 15(5):427-34. PubMed ID: 19416295
    [Abstract] [Full Text] [Related]

  • 9. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM, Babakhani F, Goldstein EJ, Nagaro K, Sambol S, Sears P, Shue YK, Gerding DN.
    Anaerobe; 2009 Dec 01; 15(6):234-6. PubMed ID: 19755166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Changing epidemiology of infections in the Netherlands in 2008/'09].
    Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ.
    Ned Tijdschr Geneeskd; 2010 Dec 01; 154():A1317. PubMed ID: 20619033
    [Abstract] [Full Text] [Related]

  • 12. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.
    O'Connor JR, Johnson S, Gerding DN.
    Gastroenterology; 2009 May 01; 136(6):1913-24. PubMed ID: 19457419
    [Abstract] [Full Text] [Related]

  • 13. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains.
    Dumford DM, Nerandzic MM, Eckstein BC, Donskey CJ.
    Am J Infect Control; 2009 Feb 01; 37(1):15-9. PubMed ID: 19171247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.
    MacCannell DR, Louie TJ, Gregson DB, Laverdiere M, Labbe AC, Laing F, Henwick S.
    J Clin Microbiol; 2006 Jun 01; 44(6):2147-52. PubMed ID: 16757612
    [Abstract] [Full Text] [Related]

  • 16. Detection of virulence genes of Clostridium difficile by multiplex PCR.
    Antikainen J, Pasanen T, Mero S, Tarkka E, Kirveskari J, Kotila S, Mentula S, Könönen E, Virolainen-Julkunen AR, Vaara M, Tissari P.
    APMIS; 2009 Aug 01; 117(8):607-13. PubMed ID: 19664132
    [Abstract] [Full Text] [Related]

  • 17. Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study.
    Huttunen R, Vuento R, Syrjänen J, Tissari P, Aittoniemi J.
    Int J Infect Dis; 2012 Jul 01; 16(7):e532-5. PubMed ID: 22572612
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
    Baines SD, O'Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, Kuijper EJ, Wilcox MH.
    J Antimicrob Chemother; 2008 Nov 01; 62(5):1046-52. PubMed ID: 18693234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.